Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)
NCT01102543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 972
Last updated 2012-04-06
Summary
The aim of Alizé is to describe a population of premature babies (gestational age (GA) \< 32 weeks) in real life situation and the management of RDS.
Conditions
- Respiratory Distress Syndrome, Newborn
Sponsors & Collaborators
-
Chiesi Farmaceutici S.p.A.
lead INDUSTRY
Principal Investigators
-
Capucine de Meynard, MD · Chiesi S.A.
Eligibility
- Min Age
- 1 Minute
- Max Age
- 12 Hours
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-10-31
- Completion
- 2011-03-31
Countries
- France
Study Locations
More Related Trials
-
Surfactant Replacement Guided by Early Lung Ultrasound Score in Preterm Newborns With Respiratory Distress Syndrome
NCT04775459 ·Status: COMPLETED
-
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
NCT03808402 ·Status: COMPLETED
-
Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes
NCT07261787 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
NCT02774044 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Less Invasive Surfactant Administration in Late Preterm or Early Term Born Infants
NCT06421506 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
NCT00767039 ·Status: TERMINATED ·Phase: PHASE4
-
A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants
NCT02305160 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of INRECSURE and LISA in Preterm Neonates With RDS
NCT05711966 ·Status: RECRUITING ·Phase: NA
-
Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant
NCT07070167 ·Status: NOT_YET_RECRUITING
-
Assessment of Ketamine and Propofol Sedation During LISA Method (Less Invasive Surfactant Administration)
NCT03705468 ·Status: COMPLETED
-
Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages
NCT03385863 ·Status: UNKNOWN
-
Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
NCT06880016 ·Status: RECRUITING ·Phase: NA
-
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
NCT01651637 ·Status: COMPLETED ·Phase: PHASE1
-
Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa
NCT06554522 ·Status: RECRUITING ·Phase: PHASE4
-
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
NCT01203358 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
NCT05898633 ·Status: COMPLETED ·Phase: PHASE1
-
Lung Ultrasound to Guide Surfactant Therapy
NCT04330443 ·Status: COMPLETED ·Phase: NA
-
Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants
NCT07176117 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Prophylactic Minimally Invasive Surfactant Evaluation
NCT06007547 ·Status: RECRUITING ·Phase: PHASE4
-
Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation
NCT01306240 ·Status: TERMINATED ·Phase: PHASE3
-
LISA in the Delivery Room for Extremely Preterm Infants
NCT04715373 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks)
NCT02958488 ·Status: COMPLETED ·Phase: NA
-
LUS AT BIRTH IN INFANTS BORN BEFORE 26 WEEKS
NCT06394583 ·Status: NOT_YET_RECRUITING
-
Does The Surfactant Administration by Aerosolization Effective?
NCT02825953 ·Status: UNKNOWN ·Phase: NA
-
Study of PREMEdication Before Laryngoscopy in Neonates in France
NCT06356909 ·Status: COMPLETED